- call +1-201-465-4211
- email sales@mrinsights.biz
Measles is a highly contagious infectious disease caused by the measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104.0 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Complications occur in about 30% of cases and may include diarrhea, blindness, inflammation of the brain, and pneumonia, among others.
Scope of the Report:
This report studies the Measles market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Measles market by product type and applications/end industries.
There is no specific antiviral treatment if measles develops. Instead the medications are generally aimed at treating super infections, maintaining good hydration with adequate fluids, and pain relief. Some groups are also given vitamin A, like young children and the severely malnourished, which act as an immunomodulator that boosts the antibody responses to measles and decreases the risk of serious complications.
The global Measles market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Measles.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Novartis
Abbott
Biomedical Diagnostics
Johnson & Johnson Services
Sanofi
Merck
Serum Institute Of India
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Red Measles
German Measles
Market Segment by Applications, can be divided into
Hospitals
Clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Measles Market Overview
1.1 Product Overview and Scope of Measles
1.2 Classification of Measles by Types
1.2.1 Global Measles Revenue Comparison by Types (2017-2023)
1.2.2 Global Measles Revenue Market Share by Types in 2017
1.2.3 Red Measles
1.2.4 German Measles
1.3 Global Measles Market by Application
1.3.1 Global Measles Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Measles Market by Regions
1.4.1 Global Measles Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Measles Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Measles Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Measles Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Measles Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Measles Status and Prospect (2013-2023)
1.5 Global Market Size of Measles (2013-2023)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Measles Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Measles Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Measles Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Measles Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biomedical Diagnostics
2.3.1 Business Overview
2.3.2 Measles Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biomedical Diagnostics Measles Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson Services
2.4.1 Business Overview
2.4.2 Measles Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Services Measles Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Measles Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Measles Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 Measles Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Measles Revenue, Gross Margin and Market Share (2016-2017)
2.7 Serum Institute Of India
2.7.1 Business Overview
2.7.2 Measles Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Serum Institute Of India Measles Revenue, Gross Margin and Market Share (2016-2017)
3 Global Measles Market Competition, by Players
3.1 Global Measles Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Measles Players Market Share
3.2.2 Top 10 Measles Players Market Share
3.3 Market Competition Trend
4 Global Measles Market Size by Regions
4.1 Global Measles Revenue and Market Share by Regions
4.2 North America Measles Revenue and Growth Rate (2013-2018)
4.3 Europe Measles Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Measles Revenue and Growth Rate (2013-2018)
4.5 South America Measles Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Measles Revenue and Growth Rate (2013-2018)
5 North America Measles Revenue by Countries
5.1 North America Measles Revenue by Countries (2013-2018)
5.2 USA Measles Revenue and Growth Rate (2013-2018)
5.3 Canada Measles Revenue and Growth Rate (2013-2018)
5.4 Mexico Measles Revenue and Growth Rate (2013-2018)
6 Europe Measles Revenue by Countries
6.1 Europe Measles Revenue by Countries (2013-2018)
6.2 Germany Measles Revenue and Growth Rate (2013-2018)
6.3 UK Measles Revenue and Growth Rate (2013-2018)
6.4 France Measles Revenue and Growth Rate (2013-2018)
6.5 Russia Measles Revenue and Growth Rate (2013-2018)
6.6 Italy Measles Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Measles Revenue by Countries
7.1 Asia-Pacific Measles Revenue by Countries (2013-2018)
7.2 China Measles Revenue and Growth Rate (2013-2018)
7.3 Japan Measles Revenue and Growth Rate (2013-2018)
7.4 Korea Measles Revenue and Growth Rate (2013-2018)
7.5 India Measles Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Measles Revenue and Growth Rate (2013-2018)
8 South America Measles Revenue by Countries
8.1 South America Measles Revenue by Countries (2013-2018)
8.2 Brazil Measles Revenue and Growth Rate (2013-2018)
8.3 Argentina Measles Revenue and Growth Rate (2013-2018)
8.4 Colombia Measles Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Measles by Countries
9.1 Middle East and Africa Measles Revenue by Countries (2013-2018)
9.2 Saudi Arabia Measles Revenue and Growth Rate (2013-2018)
9.3 UAE Measles Revenue and Growth Rate (2013-2018)
9.4 Egypt Measles Revenue and Growth Rate (2013-2018)
9.5 Nigeria Measles Revenue and Growth Rate (2013-2018)
9.6 South Africa Measles Revenue and Growth Rate (2013-2018)
10 Global Measles Market Segment by Type
10.1 Global Measles Revenue and Market Share by Type (2013-2018)
10.2 Global Measles Market Forecast by Type (2018-2023)
10.3 Red Measles Revenue Growth Rate (2013-2023)
10.4 German Measles Revenue Growth Rate (2013-2023)
11 Global Measles Market Segment by Application
11.1 Global Measles Revenue Market Share by Application (2013-2018)
11.2 Measles Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
12 Global Measles Market Size Forecast (2018-2023)
12.1 Global Measles Market Size Forecast (2018-2023)
12.2 Global Measles Market Forecast by Regions (2018-2023)
12.3 North America Measles Revenue Market Forecast (2018-2023)
12.4 Europe Measles Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Measles Revenue Market Forecast (2018-2023)
12.6 South America Measles Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Measles Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Measles Picture
Table Product Specifications of Measles
Table Global Measles and Revenue (Million USD) Market Split by Product Type
Figure Global Measle
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
